Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Search Results

Showing Results for metastatic,

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, ...

Mark CompleteCompleted
BookmarkBookmarked
Faith Abodunrin, Ayobami Olafimihan, Ari J Rosenberg

Head and neck cancer (HNC), with over 946,000 new cases and 482,000 deaths in 2022, is the seventh most common cause of cancer-related deaths globally.1 Specifically, in the USA, the number of estimated new cases in 2024 was 74,000.2 Head and neck squamous cell carcinoma (...

Mark CompleteCompleted
BookmarkBookmarked

At a time when cancer research is experiencing uncertainty and setbacks in America, the Colorectal Cancer Alliance (Alliance) is strengthening its commitment to its Project Cure CRC initiative because tomorrow can’t wait. Project Cure CRC funds cutting-edge colorectal cancer (CRC) research and aims to improve patient outcomes through its dynamic patient navigation portal, BlueHQ.org.

Mark CompleteCompleted
BookmarkBookmarked

Dr Satish Nadig describes Northwestern Medicine’s first use of the RAPID procedure to treat metastatic colorectal cancer with liver transplantation. He outlines the innovative surgical techniques, the promise of the CLEAR program, and the future potential of machine perfusion technology to extend transplant opportunities to more patients.

Mark CompleteCompleted
BookmarkBookmarked

Lung cancer is the second most common type of cancer worldwide and in the USA, with its incidence varying depending on geographic and socioeconomic factors.1–3 According to data from the Global Cancer Observatory: Cancer Incidence, Mortality and Prevalence (GLOBACAN) database, ...

Mark CompleteCompleted
BookmarkBookmarked
João Felipe Lima Feldmann, Maria Amanda Londres Lopes Pinheiro, João Henrique Lima Feldmann

Liquid biopsy: Initial concepts and application in solid tumours The US National Cancer Institute defines liquid biopsy (LB) as ‘a test done on a sample of blood to look for cancer cells from a tumour that are circulating in the ...

Mark CompleteCompleted
BookmarkBookmarked

In this interview, Prof Mark Lawler discusses the Europe’s Beating Cancer Plan key achievements, challenges and future directions.

Mark CompleteCompleted
BookmarkBookmarked

Dr. Pooja Ghatalia, an Associate Professor at Fox Chase Cancer Center, specializes in genitourinary oncology, focusing on kidney and bladder cancers. With expertise in immunotherapy and biomarker development, she combines cutting-edge research with compassionate care. Inspired by exceptional mentors, she advocates for persistence, curiosity, and patient-centered oncology, shaping future oncologists.

Mark CompleteCompleted
BookmarkBookmarked

Dr Elene Mariamidze (Todua Clinic, Tbilisi) has built a career shaped by diverse mentorship and a commitment to patient-centered oncology. She reflects on invaluable lessons from global experts, the future of oncology, and practical advice for aspiring oncologists entering this challenging yet rewarding field.

Mark CompleteCompleted
BookmarkBookmarked

Rare gastrointestinal (GI) cancers present unique challenges in diagnosis, treatment and research. Dr. Benjamin Weinberg discusses three of the rarest GI cancers: small bowel, appendix and anal cancer.

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Véronique Diéras, Dr Scott Edwards, Dr Kayla Freeman, Mrs Lesley Turner

A multidisciplinary team and a patient advocate discuss antibody–drug conjugate (ADC) related toxicities in metastatic breast cancer.

36 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Alicia Morgans, Prof. Albrecht Stenzinger, Dr Grace Cullen, Mr Tony Collier

A multidisciplinary team and a patient advocate discuss use of PARP inhibitors in mCRPC

Mark CompleteCompleted
BookmarkBookmarked

touchONCOLOGY presents the top new clinical trial findings that are generating a buzz among prostate cancer experts. Here’s the latest from one of the leading global conferences in GU oncology: the 2025 ASCO Genitourinary Cancers Symposium (February 26–28, 2025, San Francisco, CA, ...

Mark CompleteCompleted
BookmarkBookmarked

“The patient always comes first – that lesson guides every decision I make”   Dr Ari Rosenberg (University of Chicago Medicine, Chicago, IL, USA) specializes in the treatment of head and neck cancer, salivary gland cancer and thyroid cancer. His particular ...

Mark CompleteCompleted
BookmarkBookmarked

  [embed]https://www.youtube.com/watch?v=Cd77dEeZfrc[/embed] As the leading nonprofit organization dedicated to ending the disease, the Colorectal Cancer Alliance (Alliance) continues to break boundaries in colorectal cancer care. Its Project Cure CRC research initiative ...

Load More...
Close Popup